摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl O,alpha-dimethyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]-DL-tyrosinate | 163798-86-5

中文名称
——
中文别名
——
英文名称
methyl O,alpha-dimethyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]-DL-tyrosinate
英文别名
methyl 2-(2-adamantyloxycarbonylamino)-3-(4-methoxyphenyl)-2-methylpropanoate
methyl O,alpha-dimethyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]-DL-tyrosinate化学式
CAS
163798-86-5
化学式
C23H31NO5
mdl
——
分子量
401.503
InChiKey
ACNGHPSXMSTTFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    29
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    73.9
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    methyl O,alpha-dimethyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]-DL-tyrosinate 在 lithium hydroxide 作用下, 以 1,4-二氧六环 为溶剂, 生成 O,alpha-dimethyl-N-[(tricyclo[3.3.1.13,7]dec-2-yloxy)carbonyl]-DL-tyrosine
    参考文献:
    名称:
    SAR study of the indole moiety of CI-988, a potent and selective CCK-B antagonist
    摘要:
    Due to the interesting pharmacological activity observed for CI-988, a potent and selective CCK-B receptor antagonist, we have continued to study the SAR of this antagonist. This particular study examines the importance of the indole moiety for binding affinity. The synthesis and receptor binding affinity for analogs containing functionalized indole derivatives and replacing the indole with various heterocycles are reported. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)00356-9
  • 作为产物:
    参考文献:
    名称:
    SAR study of the indole moiety of CI-988, a potent and selective CCK-B antagonist
    摘要:
    Due to the interesting pharmacological activity observed for CI-988, a potent and selective CCK-B receptor antagonist, we have continued to study the SAR of this antagonist. This particular study examines the importance of the indole moiety for binding affinity. The synthesis and receptor binding affinity for analogs containing functionalized indole derivatives and replacing the indole with various heterocycles are reported. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)00356-9
点击查看最新优质反应信息

文献信息

  • Amino acid analogs as CCK antagonists
    申请人:Warner-Lambert Company
    公开号:US05331006A1
    公开(公告)日:1994-07-19
    Novel unnatural dipeptoids useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the compounds are antianxiety agents and antiulcer agents. The compounds are agents useful for preventing the response to withdrawal from chronic treatment or use of nicotine, diazepam, alcohol, cocaine, caffeine, and opioids. The compounds are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare diagnostic compositions.
    本发明揭示了一种新型的不自然二肽衍生物,其可用作治疗肥胖、消化道胃酸过多、胃泌素依赖性肿瘤或作为抗精神病药物的药剂。此外,这些化合物还具有抗焦虑和抗溃疡的作用。这些化合物可用于预防尼古丁、地西泮、酒精、可卡因、咖啡因和阿片类药物的慢性治疗或使用引起的戒断反应。这些化合物还可用于治疗和/或预防惊恐发作。此外,本发明还揭示了使用这些二肽衍生物制备药物组合物和治疗方法,以及用于制备诊断组合物的新型中间体。
  • [EN] AMINO ACID ANALOGS AS CCK ANTAGONISTS
    申请人:WARNER-LAMBERT COMPANY
    公开号:WO1992004025A1
    公开(公告)日:1992-03-19
    (EN) Novel unnatural dipeptoids useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the compounds are antianxiety agents and antiulcer agents. The compounds are agents useful for preventing the response to withdrawal from chronic treatment or use of nicotine, diazepam, alcohol, cocaine, caffeine, and opioids. The compounds are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare diagnostic compositions.(FR) L'invention se rapporte à de nouveaux dipeptoïdes non naturels, qui sont utiles comme agents de traitement de l'obésité, de l'hypersécrétion d'acide gastrique dans l'intestin, de tumeurs dépendantes de la gastrine ou comme neuroleptiques. Ces composés peuvent en outre servir d'anxiolytiques et d'agents anti-ulcéreux. Ils sont utiles pour empêcher la réaction à l'arrêt d'un traitement chronique à la nicotine, au diazépam, à l'alcool, à la cocaïne, à la caféine et aux opioïdes ou d'un usage chronique de ces substances. Ces composés sont également utiles dans le traitement et/ou la prévention des crises de panique. La présente invention décrit aussi des compositions pharmaceutiques et des procédés de traitement qui utilisent ces dipeptoïdes, ainsi que des processus de préparation de ces dipeptoïdes et de nouveaux intermédiaires utiles dans leur préparation. Une autre caractéristique de la présente invention est l'utilisation de ces composés dans la préparation de compositions diagnostiques.
  • SAR study of the indole moiety of CI-988, a potent and selective CCK-B antagonist
    作者:Corinne E. Augelli-Szafran、Terri S. Purchase、Bruce D. Roth、Bradley Tait、Bharat K. Trivedi、Michael Wilson、Nirmala Suman-Chauhan、Louise Webdale
    DOI:10.1016/s0960-894x(97)00356-9
    日期:1997.8
    Due to the interesting pharmacological activity observed for CI-988, a potent and selective CCK-B receptor antagonist, we have continued to study the SAR of this antagonist. This particular study examines the importance of the indole moiety for binding affinity. The synthesis and receptor binding affinity for analogs containing functionalized indole derivatives and replacing the indole with various heterocycles are reported. (C) 1997 Elsevier Science Ltd.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐